I & EHTH INVESTOR UPDATE: Bronstein, Gewirtz & Grossman LLC Updates Investors of Class Actions and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 6, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Intelsat S.A. (NYSE:I)
Class Period: November 5, 2019 – November 18, 2019
Deadline: June 8, 2020
For more info: www.bgandg.com/i

The Complaint alleges that throughout the Class Period, defendants made false and misleading statements to the market. The complaint alleges that Intelsat violated the Exchange Act by selling a block of the Company's shares while holding material non-public information, including the fact that the Company had met with the FCC on November 5, 2019, regarding the private sale of wavebands controlled by Intelsat for future "5G" use (the "C-Band"). The FCC opposed the Company's existing plans for a private sale of the C-Band, preferring a public auction. The FCC announced a public auction of the C-Band on November 18, 2019, contrary to the Intelsat wishes, its stock dropped 40%.

eHealth, Inc. (NASDAQ:EHTH)
Class Period: March 19, 2018 – April 7, 2020
Deadline: June 8, 2020
For more info: www.bgandg.com/ehth

The Complaint alleges that throughout the Class Period, defendants made false and misleading and/or failed to disclose that: (1) it had highly aggressive accounting and modeling assumptions; (2) it suffered from skyrocketing rate of member churn, resulting from eHealth's pursuit of low quality, lossmaking growth; (3) it relied on direct response television advertising, which attracts an unprofitable, high churn enrollee; and (4) as a result of the foregoing, defendants' public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 588187